U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT06871826) titled 'Tissue Inhibitor of Metalloproteinases 2 Level in Patients Undergoing Cardiac Surgery' on March 07.
Brief Summary: Acute kidney injury (AKI) is one of the most frequent major complications in patients undergoing cardiac surgery. CSA-AKI is independently related to increased perioperative mortality, increased hospital and ICU length of stay as well as heath care expenditure. Identification of relevant biomarkers may lead to early diagnosis and improve patient outcomes and health care costs. The pathophysiology of CSA-AKI is complex and ischemia-reperfusion injury is one of the important factors. Recently, it has been shown that Tiss...